*  Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies - Full Text View - ClinicalTrials.gov
Condition Intervention Phase Hematologic Malignancies Other: Fludarabine, Cytoxan, TBI, Sirolimus + MMF Other: Fludarabine, ... Post-Transplantation Immunosuppression Consisting of:. *Day 3 and 4: High-dose Cytoxan 50mg/kg/day (adjusted according to IBW) ... Post-Transplantation Immunosuppression Consisting of:. *Day 3 and 4: High-dose Cytoxan 50mg/kg/day (adjusted according to IBW) ... Pre-transplantation:. *Day -6 through -2: Fludarabine 30 mg/m2/day (adjusted for renal function; maximum cumulative dose, 150 ...
  https://clinicaltrials.gov/ct2/show/NCT01203722
*  Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
New conditioning regimens are still needed to maximize efficacy and limit treatment-related deaths of allogeneic ... Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies. Trial Phase:. N/A. Minimum ... Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies. Treatment-related ... failures in allogeneic transplantation for advanced hematologic malignancies. The most. commonly utilized conditioning regimens ...
  http://www.knowcancer.com/cancer-trials/NCT01499147/
*  Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis -...
Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis. ... Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis. ... Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation Undergo transplantation. Procedure: quality-of- ... Condition or disease Intervention/treatment Phase Systemic Scleroderma Severe Systemic Sclerosis Drug: fludarabine phosphate ...
  https://clinicaltrials.gov/ct2/show/NCT00622895?cond=%22systemic+scleroderma%22&rank=3
*  Non-Myeloablative Conditioning and Bone Marrow Transplantation - Full Text View - ClinicalTrials.gov
Non-Myeloablative Conditioning and Bone Marrow Transplantation. This study is currently recruiting participants. See Contacts ... Experimental: Non-Myeloablative Conditioning and Bone Marrow Transplantation Drug: Thymoglobulin Day 9 - 0.5 mg/kg IV before ... A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients With ... Procedure: Bone marrow transplantation Day 0 - Transplantation of hematopoietic cells derived from bone marrow of a donor to a ...
  https://clinicaltrials.gov/ct2/show/NCT01850108?recr=Open&intr=bone+marrow+transplantation&rank=7
*  Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for...
Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for ... Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for ... Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for ... Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for ...
  http://www.bloodjournal.org/content/105/10/4143?sso-checked=true
*  Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) - Full Text View - ClinicalTrials.gov
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT). The safety and scientific validity of ... Condition or disease Intervention/treatment Phase Leukemia Lymphoma Drug: Rituximab Drug: 111In Ibritumomab Procedure: Planar ... Containing Non-Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in B-cell Malignancies. ... Stem Cell Transplantation. Planar Scintigraphy. Spect Scan. Single Photon Emission-Computed Tomography. CT Scan. Computed ...
  https://clinicaltrials.gov/ct2/show/NCT01490723?recr=Open&spons=spectrum+pharmaceuticals&rank=12
*  Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma
This trial will evaluate the efficacy and the safety of a strategy of allogeneic stem cell transplantation including Rituximab ... Allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning. (RIC-allo) is an option for patients ... Safety and Efficacy of a Strategy of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning ... Safety and Efficacy of a Strategy of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning ...
  http://www.knowcancer.com/cancer-trials/NCT01208896/
*  Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia - Full Text View - ClinicalTrials.gov
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia. The safety and scientific validity of ... Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From HLA-Compatible Unrelated Donors in Severe Aplastic ... Condition or disease Intervention/treatment Phase Aplastic Anemia Drug: Antithymocyte Globulin Drug: Cyclophosphamide Drug: ... MedlinePlus related topics: Anemia Aplastic Anemia Bone Marrow Transplantation Drug Information available for: Cyclophosphamide ...
  https://clinicaltrials.gov/ct2/show/NCT00474747?recr=Open&cond=%22Anemia%2C+Aplastic%22&rank=11
*  Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia - Full Text View - ClinicalTrials.gov
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia. This study has been completed. ... Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From HLA-Compatible Unrelated Donors in Severe Aplastic ... Condition Intervention Phase Aplastic Anemia Drug: Antithymocyte Globulin Drug: Cyclophosphamide Drug: Fludarabine Radiation: ... MedlinePlus related topics: Anemia Aplastic Anemia Bone Marrow Transplantation Drug Information available for: Cyclophosphamide ...
  https://clinicaltrials.gov/ct2/show/NCT00474747?term=aplastic+anemia&recr=Open&fund=01&rank=11
*  Terms and Conditions : Current Opinion in Organ Transplantation
Other terms and conditions, in addition to these Terms and Conditions, may appear on the Site related to specific content of ... These Terms and Conditions represent the entire agreement between you and WKH with respect to the subject matter hereof, and ... Terms and Conditions of Use. Wolters Kluwer Health, Inc., its parent, affiliate and subsidiary companies including but not ... WKH reserves the right to terminate your access to the Site in the event that you violate these Terms and Conditions or for any ...
  http://journals.lww.com/co-transplantation/_layouts/15/oaks.journals/terms.aspx
*  Study demonstrates safety of cord blood stem cell transplantation protocol to treat neurological conditions
... in Shenzhen using Beike's proprietary cord blood stem cell transplantation protocol. ... Study demonstrates safety of cord blood stem cell transplantation protocol to treat neurological conditions. *Download PDF Copy ... Posted in: Medical Procedure News , Medical Science News , Medical Condition News. Tags: Biotechnology, Blood, Bone, Bone ... News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that ...
  https://www.news-medical.net/news/20100903/Study-demonstrates-safety-of-cord-blood-stem-cell-transplantation-protocol-to-treat-neurological-conditions.aspx
*  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a...
... dose deescalation in a fludarabine-based conditioning regimen for bone marrow transplantation from unrelated donors in patients ... Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a ... dose deescalation in a fludarabine-based conditioning regimen for bone marrow transplantation from unrelated donors in patients ...
  http://www.aamds.org/node/1289
*  NewYork-Presbyterian Queens - Heart Conditions in Children - Heart Transplantation
Heart Conditions in Children - Heart Transplantation. What is a heart transplant?. A heart transplant is an operation performed ... The length of time your child will spend in the ICU will vary based on your child's unique condition. After your child is ... Availability of donors for heart transplantation is also affected by the size of the child needing the transplant. For instance ... Several other team members will evaluate your child before transplantation and provide follow-up care, as needed. These include ...
  http://www.nyhq.org/diw/content.asp?PageID=P06363&More=DIW
*  BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma
... 2016-07-20 02:38:22 , ... Home » Topics » Clincial Trials » Research » BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non- ... More From BioPortfolio on "BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma". ... Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma. ...
  https://www.bioportfolio.com/resources/trial/162212/BEB-Conditioning-Regimen-for-Autologous-Stem-cell-Transplantation-ASCT-in-Non-Hodgkins.html
*  Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients...
Non-myeloablative conditioning regimens followed by allogeneic hematopoietic cell transplantation (HCT) have opened the way to ... 2006) Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new ... 2005) Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin ... Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients ...
  http://www.haematologica.org/content/96/2/298
*  Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML - Full Text View -...
Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML. The safety and ... Phase II Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric Acute Myeloid ... As the TRM is higher in CBT especially after conventional myeloablative conditioning, non-myeloablative conditioning regimens ... Condition or disease Intervention/treatment Phase Acute Myeloid Leukemia Drug: Fludarabine, Busulfan, Thymoglobulin Phase 1 ...
  https://clinicaltrials.gov/ct2/show/NCT00887042
*  Reduced intensity conditioning and allogeneic stem cell transplantation in children and adolescents with malignancies from...
Reduced intensity conditioning and allogeneic stem cell transplantation in children and adolescents with malignancies from ... Reduced intensity conditioning and allogeneic stem cell transplantation in children and adolescents with malignancies from ... Reduced intensity conditioning and allogeneic stem cell transplantation in children and adolescents with malignancies from ... Reduced intensity conditioning and allogeneic stem cell transplantation in children and adolescents with malignancies from ...
  http://cancerres.aacrjournals.org/content/64/7_Supplement/718.1
*  Syngeneic transplantation in aplastic anemia: pretransplant conditioning and peripheral blood are associated with improved...
... analysis of all syngeneic transplants for aplastic anemia reported to the European Group for Blood and Marrow Transplantation. ... Syngeneic transplantation in aplastic anemia: pretransplant conditioning and peripheral blood are associated with improved ... In summary, syngeneic transplant is associated with a significant risk of graft failure when no conditioning is given, but has ... Most transplants (n=85) were preceded by a conditioning regimen, 22 of these including anti- thymocyte globulin. About half of ...
  http://www.aamds.org/node/2039
*  Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell...
Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation ... A Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell ... Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell ... to a standard busulfan and fludarabine conditioning treatment has. The study will also look at what causes some people to have ...
  https://clinicaltrials.gov/ct2/show/record/NCT01596699
*  Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous...
Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous ... Transplantation-related mortality and toxicities [ Time Frame: 1, 3, 6 and 12 months after transplantation ]. To evaluate 1- ... Patients who need hematopoietic stem cell transplantation with busulfan based conditioning regimen. ... Previous myeloablative conditioning regimen has problems related to the severe toxicities, and non-myeloablative conditioning ...
  https://clinicaltrials.gov/ct2/show/NCT01338675?recr=Open&cond=%22Granulomatous+Disease%2C+Chronic%22&rank=5
*  Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning |...
Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning. Toxicity ... Hentschke P, Barkholt L, Uzunel M, et al Low-intensity conditioning and hematopoietic stem cell transplantation in patients ... Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning ... Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning ...
  http://clincancerres.aacrjournals.org/content/10/23/7799
*  Acquired long QT syndrome during conditioning for allogeneic stem cell transplantation-are we aware of this side effect? |...
Acquired long QT syndrome during conditioning for allogeneic stem cell transplantation-are we aware of this side effect?. ... reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high- ... Marks R, Potthoff K, Hahn J, Ihorst G, Bertz H, Spyridonidis A, Holler E, Finke JM (2008) Reduced-toxicity conditioning with ... Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)- ...
  https://rd.springer.com/article/10.1007/s00277-018-3262-4
*  Phase II study of the adjuvant use of lenalidomide in patients undergoing reduced intensity conditioning allogenic...
This trial aims to investigate the efficacy of lenalidomide as adjuvant therapy following a reduced-intensity conditioning ... II study of the adjuvant use of lenalidomide in patients undergoing reduced intensity conditioning allogenic transplantation ... Privacy Policy, Disclaimer, General Terms & Conditions Not logged in Unaffiliated 54.81.128.172 ... II study of the adjuvant use of lenalidomide in patients undergoing reduced intensity conditioning allogenic transplantation ...
  https://adisinsight.springer.com/trials/700198852?error=cookies_not_supported&code=26bb8c7b-2c84-408d-b1ec-5696e6ac4228
*  Study of a Reduced-toxicity 'Submyeloablative' Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients...
Allogeneic stem cell transplantation. Reduced-intensity conditioning. Reduced-toxicity conditioning. Hematological malignancies ... Phase II Study of a Reduced-toxicity ' Submyeloablative ' Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in ... Study of a Reduced-toxicity 'Submyeloablative' Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients ... Condition or disease Intervention/treatment Phase Hematological Malignancies Drug: Fludarabine, Busulfan, Thymoglobuline Phase ...
  https://clinicaltrials.gov/ct2/show/NCT00841724
*  List of conditions treated with hematopoietic stem cell transplantation - Wikipedia
Hematopoietic stem cell transplantation may be used to treat a number of conditions both congenital and acquired. Malignancies ... "Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation". N Engl J Med. 360 (7): 692-698. doi:10.1056/ ...
  https://en.wikipedia.org/wiki/List_of_conditions_treated_with_hematopoietic_stem_cell_transplantation